October 26, 2023 | Advisory board, Build KOL partnership, DOL, HCP, HCP relationships, Hybrid meetings, Impetus Digital, KOL, KOL relationships, MSL, MSL relationships, Online advisory board, VAB, Virtual advisory board, advisory board tips, digital advisory board
Here’s another top reason why virtual advisory boards are simply better than in-person and hybrid advisory boards.
#4. More Frequent Interactions and Long-lasting KOL Relationships
Another important benefit of online advisory boards is that they allow much more frequent interactions for the same cost as a yearly in-person meeting. By conducting an advisory board touchpoint every couple of months instead of annually, you ensure ongoing interactions and continuously evolving relationships with your KOLs. In turn, you receive a steady stream of high-quality insights over time and build authentic partnerships with these key stakeholders in the process. With closer relationships come trust, honesty, and openness–things that every brand team should strive for in their KOL relationships.
More frequent touchpoint activities are especially useful when dealing with the quickly changing competitive landscape or newly published data. Issues do not normally arise overnight nor are they solved overnight. Ongoing touchpoints allow for rumination of data and timely problem-solving, and the collection of insights occurs in more easily digestible segments. Consequently, this builds a logical story flow that results in better long-term cognition and higher behavioral impact.
To learn more about this and other great benefits of virtual advisory boards, check out our blog https://www.impetusdigital.com/2021/09/17/top-10-benefits-of-virtual-advisory-boards/
Interested in learning how we can help you engage your advisors, HCPs, patients, and stakeholders with expertly executed virtual meetings and programs? Visit us at www.impetusdigital.com or talk to one of our amazing team members via https://meetwithimpetus.com/
Follow us on social media
https://linkedin.com/company/impetus-digital
https://twitter.com/impetus_digital
https://facebook.com/ImpetusDigital.fb
https://impetusdigital.com/podcast/
This content was provided by Impetus Digital
Company Details
Latest Content from Impetus Digital
Brad Womble, Senior Director of Strategy, Marketing and Mergers & Acquisitions, at Jabil Healthcare dives into several thought-provoking topics, including how insights from “digital twins” can be used to improve...
Real-world methodology & results from hosting an ongoing, nationwide Digital Content Council...
Anthony Capone, President of DocGo, shares how his company uses last-mile mobile health services and integrated medical transportation solutions to make healthcare more accessible for everyone, including underserved populations.
Lawrence Bressler, Head of Value & Market Access, Global Rare Diseases at Chiesi, shares how Chiesi is revolutionizing the lives of people living with rare diseases on a global scale....
Marius Rus, founder of StressLess–the startup behind Tully–discusses wearable technologies for children with ADHD, autism, and other mental health conditions. He also shares his tips and lessons learned from founding...
Dr. Luca Dezzani, VP of US Oncology Medical Affairs at Johnson & Johnson, explores innovation in Medical Affairs, new technologies for data dissemination and medical education, how to engage with...
One definition of patient-centricity is “Putting the patient first in an open and sustained engagement of the patient to respectfully and compassionately achieve the best experience and outcome for that person...
Robert Kaul, Founder, CEO & President of Cloud DX, explores connected health, remote patient monitoring, telemedicine, and more. He also shares his tips for new entrepreneurs based on his 17...
Dr. Tarry Ahuja, Manager of Program Development in Pharmaceutical Reviews and Senior RWE Advisor at CADTH, explores the impact of COVID-19 on the biopsychosocial model of health, key opportunities and...
Chris Garabedian, CEO of Xontogeny, dives into biotech and digital health innovation, current industry gaps and obstacles, how to encourage biotech entrepreneurs, AI & machine learning, and much more!